Status:
COMPLETED
Efficacay of Chloroquine or Hydroxychloroquine in COVID-19 Treatment
Lead Sponsor:
Tanta University
Conditions:
COVID-19
Coronavirus Infection
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Chloroquine or hydroxychloroquine in COVID-19 treatment
Detailed Description
Clinical Study Evaluating the Efficacy of Chloroquine or hydroxychloroquine in COVID-19 treatment
Eligibility Criteria
Inclusion
- Covid 19 patients
Exclusion
- Allergy or contraindication to the drug
- Pregnant or lactating
- Patients with cardiac problems
Key Trial Info
Start Date :
March 23 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
194 Patients enrolled
Trial Details
Trial ID
NCT04353336
Start Date
March 23 2020
End Date
July 1 2020
Last Update
August 2 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tanta University, Assiut University
Tanta, Egypt, 35111